Treatment IND in Egypt
How the treatment ind pathway operates in Egypt.
About Treatment IND
US FDA treatment Investigational New Drug category.
How Treatment IND works in Egypt
Egypt's EDA permits personal-use import of non-registered drugs under physician supervision; process is paperwork-heavy but viable.
Patients in Egypt seeking access under Treatment IND typically follow this flow: a licensed physician in Egypt issues the prescription and clinical justification, the regulator reviews and authorises, and an authorised operator coordinates import.
Documents required in Egypt
- Physician prescription and clinical-justification letter.
- Patient identification and consent.
- Country-specific NPP/personal-import form.
- Hospital or clinic attestation where required.
Typical timeline
End-to-end 2-6 weeks in most tier 2 jurisdictions. Cellular and gene therapies may require additional ethics-committee review.